No time to 'weight': The link between obesity and stroke in women

Women's Health

Volumn 7, Issue 4, 2011, Pages 453-463

  Antillon, Daphne ^a   Towfighi, Amytis ^b,c  

^a LOMA LINDA UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c RANCHO LOS AMIGOS NATIONAL REHABILITATION CENTER   (United States)

Author keywords

abdominal obesity; BMI; hemorrhagic stroke; ischemic stroke; metabolic syndrome; obesity; waist circumference; waist to hip ratio; women

Indexed keywords

ABDOMINAL OBESITY; ACCURACY; BODY MASS; BODY WEIGHT; CEREBROVASCULAR ACCIDENT; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GEOGRAPHIC DISTRIBUTION; HUMAN; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; MORTALITY; OBESITY; PATHOPHYSIOLOGY; PATIENT ATTITUDE; PHYSICAL ACTIVITY; PREDICTION; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; TREND STUDY; WOMEN'S HEALTH;

BODY WEIGHT; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; STROKE; UNITED STATES; WOMEN'S HEALTH;

EID: 79960934703     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.11.36     Document Type: Review

References (111)

1. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 52(5), 818-827 (2008).
2. Hyre AD, Muntner P, Menke A, Raggi P, He J. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann. Epidemiol. 17(7), 548-555 (2007). (Pubitemid 46950925)
3. Gregg EW, Cheng YJ, Cadwell BL et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 293(15), 1868-1874 (2005). (Pubitemid 40548183)
4. Cowie CC, Rust KF, Ford ES et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005- 2006. Diabetes Care 32(2), 287-294 (2009).
5. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303(3), 235-241 (2010).
6. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) 16(10), 2323-2330 (2008).
7. Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 123(4), e18-e209 (2011).
8. Lloyd-Jones D, Adams RJ, Brown TM et al. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 121(7), e46-e215 (2010).
9. Gargano JW, Reeves MJ, for the Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators. Sex differences in stroke recovery and stroke-specific quality of life: results from a statewide stroke registry. Stroke 38(9), 2541-2548 (2007). (Pubitemid 47329635)
10. Towfighi A, Saver JL, Engelhardt R, Ovbiagele B. A midlife stroke surge among women in the United States. Neurology 69(20), 1898-1904 (2007). (Pubitemid 350103453)
11. Towfighi A, Zheng L, Ovbiagele B. Weight of the obesity epidemic: rising stroke rates among middle-aged women in the United States. Stroke 41(7), 1371-1375 (2010).
12. Towfighi A, Markovic D, Ovbiagele B. Persistent Sex disparity in midlife stroke prevalence in the United States. Cerebrovasc. Dis. 31(4), 322-328 (2011).
13. Rexrode KM, Hennekens CH, Willett WC et al. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 277(19), 1539-1545 (1997). (Pubitemid 27213303)
14. Zhang X, Shu XO, Gao YT, Yang G, Li H, Zheng W. General and abdominal adiposity and risk of stroke in Chinese women. Stroke 40(4), 1098-1104 (2009).
15. Strazzullo P, D'elia L, Cairella G, Garbagnati F, Cappuccio FP, Scalfi L. Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants. Stroke 41(5), e418-e426 (2010).
16. Yatsuya H, Folsom AR, Yamagishi K, North KE, Brancati FL, Stevens J. Race-and sex-specific associations of obesity measures with ischemic stroke incidence in the Atherosclerosis Risk in Communities (ARIC) study. Stroke 41(3), 417-425 (2010).
17. Kurth T, Gaziano JM, Rexrode KM et al. Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation 111(15), 1992-1998 (2005). (Pubitemid 40570220)
18. Winter Y, Rohrmann S, Linseisen J et al. Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke 39(12), 3145-3151 (2008).
19. Saito I, Iso H, Kokubo Y, Inoue M, Tsugane S. Body mass index, weight change and risk of stroke and stroke subtypes: the Japan Public Health Center-Based Prospective (JPHC) study. Int. J. Obes. (Lond.) 35(2), 283-291 (2011).
20. Hu G, Tuomilehto J, Silventoinen K, Sarti C, Mannisto S, Jousilahti P. Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch. Intern. Med. 167(13), 1420-1427 (2007). (Pubitemid 47052442)
21. Bazzano LA, Gu D, Whelton MR et al. Body mass index and risk of stroke among Chinese men and women. Ann. Neurol. 67(1), 11-20 (2010).
22. Boden-Albala B, Sacco RL, Lee HS et al. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke 39(1), 30-35 (2008).
23. Park Y-W, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The Metabolic syndrome: prevalence and associated risk factor findings in the US population from the third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 163(4), 427-436 (2003). (Pubitemid 36241019)
24. Suk SH, Sacco RL, Boden-Albala B et al. Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke 34(7), 1586-1592 (2003). (Pubitemid 36842606)
25. Asplund K, Karvanen J, Giampaoli S et al. Relative risks for stroke by age, sex, and population based on follow-up of 18 European populations in the MORGAM project. Stroke 40(7), 2319-2326 (2009).
26. Lu M, Ye W, Adami HO, Weiderpass E. Prospective study of body size and risk for stroke amongst women below age 60. J. Intern. Med. 260(5), 442-450 (2006). (Pubitemid 44571132)
27. Lovejoy JC, Sainsbury A, Stock Conference 2008 Working Group. Sex differences in obesity and the regulation of energy homeostasis. Obes. Rev. 10(2), 154-167 (2009).
28. Snijder M, Van Dam R, Visser M, Seidell J. What aspects of body fat are particularly hazardous and how do we measure them? Int. J. Epidemiol. 35(1), 83-92 (2006). (Pubitemid 43205452)
29. De Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur. Heart J. 28(7), 850-856 (2007). (Pubitemid 47343598)
30. Milionis HJ, Filippatos TD, Derdemezis CS et al. Excess body weight and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects. Eur. J. Neurol. 14(7), 762-769 (2007). (Pubitemid 47012185)
31. Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M, Kuusisto J. The metabolic syndrome predicts incident stroke: a 14-year follow-up study in elderly people in Finland. Stroke 39(4), 1078-1083 (2008). (Pubitemid 351444669)
32. Samaras TT, Elrick H, Storms LH. Is short height really a risk factor for coronary heart disease and stroke mortality? A review. Med. Sci. Monit. 10(4), RA63-RA76 (2004). (Pubitemid 38525093)
33. Grundy SM. Metabolic syndrome pandemic. Arterioscler. Thromb. Vasc. Biol. 28(4), 629-636 (2008). (Pubitemid 351651324)
34. Gami AS, Witt BJ, Howard DE et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 49(4), 403-414 (2007). (Pubitemid 46135879)
35. Najarian RM, Sullivan LM, Kannel WB, Wilson PW, D'Agostino RB, Wolf PA. Metabolic syndrome compared with Type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch. Intern. Med. 166(1), 106-111 (2006). (Pubitemid 43063849)
36. Towfighi A, Ovbiagele B. Metabolic syndrome and stroke. Curr. Diab. Rep. 8(1), 37-41 (2008). (Pubitemid 351384874)
37. Chen HJ, Bai CH, Yeh WT, Chiu HC, Pan WH. Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke 37(4), 1060-1064 (2006).
38. Chen K, Lindsey JB, Khera A et al. Independent associations between metabolic syndrome, diabetes mellitus and atherosclerosis: observations from the Dallas Heart Study. Diab. Vasc. Dis. Res. 5(2), 96-101 (2008). (Pubitemid 351839280)
39. Kurl S, Laukkanen JA, Niskanen L et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 37(3), 806-811 (2006). (Pubitemid 43731913)
40. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the third National Health and Nutrition Examination Survey. Circulation 109(1), 42-46 (2004). (Pubitemid 38056019)
41. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic Syndrome vs Framingham risk score for prediction of coronary heart disease, stroke, and Type 2 diabetes mellitus. Arch. Intern. Med. 165(22), 2644-2650 (2005). (Pubitemid 41785063)
42. Takahashi K, Bokura H, Kobayashi S, Iijima K, Nagai A, Yamaguchi S. Metabolic syndrome increases the risk of ischemic stroke in women. Intern. Med. 46(10), 643-648 (2007). (Pubitemid 46845833)
43. Li W, Ma D, Liu M et al. Association between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies. Cerebrovasc. Dis. 25(6), 539-547 (2008). (Pubitemid 351861472)
44. Milionis HJ, Rizos E, Goudevenos J, Seferiadis K, Mikhailidis DP, Elisaf MS. Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects. Stroke 36(7), 1372-1376 (2005). (Pubitemid 40967496)
45. Furie KL, Kasner SE, Adams RJ et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 42(1), 227-276 (2011).
46. Protopsaltis I, Korantzopoulos P, Milionis HJ et al. Metabolic syndrome and its components as predictors of ischemic stroke in Type 2 diabetic patients. Stroke 39(3), 1036-1038 (2008). (Pubitemid 351619571)
47. Ford ES, Li C, Zhao G, Tsai J. Trends in obesity and abdominal obesity among adults in the United States from 1999-2008. Int. J. Obes. (Lond.) 35(5), 736-743 (2010).
48. Verma S, Wang CH, Li SH et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106(8), 913-919 (2002). (Pubitemid 34925323)
49. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 106(12), 1439-1441 (2002).
50. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA 290(22), 2945-2951 (2003). (Pubitemid 37505526)
51. Rexrode KM, Pradhan A, Manson JE, Buring JE, Ridker PM. Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann. Epidemiol. 13(10), 674-682 (2003). (Pubitemid 37346407)
52. Després J-P. Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk. Heart 95(13), 1118-1124 (2009).
53. Haffner SM. Insulin resistance, inflammation, and the prediabetic state. Am. J. Cardiol. 92(4A), J18-J26 (2003).
54. Olijhoek JK, van der Graaf Y, Banga J-D, Algra A, Rabelink TJ, Visseren FLJ. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur. Heart J. 25(4), 342-348 (2004). (Pubitemid 38295444)
55. Park JH, Kwon HM, Roh JK. Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis. Eur. J. Neurol.14(4), 379-386 (2007).
56. Bonora E, Kiechl S, Willeit J et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome. Diabetes Care 26(4), 1251-1257 (2003).
57. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N. Engl. J. Med. 348(26), 2599-2608 (2003). (Pubitemid 36741587)
58. Liu S, Manson JE, Lee IM et al. Fruit and vegetable intake and risk of cardiovascular disease: The Women's Health Study. Am. J. Clin. Nutr. 72(4), 922-928 (2000).
59. Huijbregts P, Feskens E, Rasanen L et al. Dietary pattern and 20 year mortality in elderly men in Finland, Italy, and The Netherlands: longitudinal cohort study. BMJ 315(7099), 13-17 (1997). (Pubitemid 27271676)
60. Mensink GB, Deketh M, Mul MD, Schuit AJ, Hoffmeister H. Physical activity and its association with cardiovascular risk factors and mortality. Epidemiology 7(4), 391-397 (1996). (Pubitemid 26202185)
61. Lee IM, Paffenbarger RS Jr. Physical activity and stroke incidence: the Harvard Alumni Health Study. Stroke 29(10), 2049-2054 (1998). (Pubitemid 28443516)
62. Tanasescu M, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Exercise type and intensity in relation to coronary heart disease in men. JAMA 288(16), 1994-2000 (2002). (Pubitemid 35204689)
63. Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am. J. Epidemiol. 132(4), 612-628 (1990). (Pubitemid 20344530)
64. Leon AS, Connett J. Physical activity and 10.5 year mortality in the multiple risk factor intervention trial (MRFIT).Int. J. Epidemiol. 20(3), 690-697 (1991).
65. Leon AS, Myers MJ, Connett J. Leisure time physical activity and the 16-year risks of mortality from coronary heart disease and all-causes in the multiple risk factor intervention trial (MRFIT).Int. J. Sports Med. 18(Suppl. 3), S208-S215 (1997).
66. Kawachi I, Colditz GA, Stampfer MJ et al. Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Ann. Intern. Med. 119(10), 992-1000 (1993). (Pubitemid 23334655)
67. Kawachi I, Colditz GA, Stampfer MJ et al. Smoking cessation and decreased risk of stroke in women. JAMA 269(2), 232-236 (1993).
68. Kawachi I, Colditz GA, Stampfer MJ et al. Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. Arch. Intern. Med. 154(2), 169-175 (1994). (Pubitemid 24032191)
69. Mukamal KJ, Ascherio A, Mittleman MA et al. Alcohol and risk for ischemic stroke in men: the role of drinking patterns and usual beverage. Ann. Intern. Med. 142(1), 11-19 (2005).
70. Mukamal KJ, Conigrave KM, Mittleman MA et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N. Engl. J. Med. 348(2), 109-118 (2003). (Pubitemid 36056717)
71. White IR, Altmann DR, Nanchahal K. Alcohol consumption and mortality: modelling risks for men and women at different ages. BMJ 325(7357), 191 (2002).
72. White IR, Altmann DR, Nanchahal K. Mortality in England and Wales attributable to any drinking, drinking above sensible limits and drinking above lowest-risk level. Addiction 99(6), 749-756 (2004). (Pubitemid 38747912)
73. Liao Y, Mcgee DL, Cao G, Cooper RS. Alcohol intake and mortality: findings from the National Health Interview Surveys (1988 and 1990).Am. J. Epidemiol. 151(7), 651-659 (2000). (Pubitemid 30463586)
74. Kurth T, Gaziano JM, Berger K et al. Body mass index and the risk of stroke in men. Arch. Intern. Med. 162(22), 2557-2562 (2002). (Pubitemid 35453494)
75. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N. Engl. J. Med. 343(1), 16-22 (2000). (Pubitemid 30447987)
76. Knoops KT, De Groot LC, Kromhout D et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 292(12), 1433-1439 (2004). (Pubitemid 39258335)
77. Chiuve SE, Mccullough ML, Sacks FM, Rimm EB. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Circulation 114(2), 160-167 (2006). (Pubitemid 44420748)
78. Kurth T, Moore SC, Gaziano JM et al. Healthy lifestyle and the risk of stroke in women. Arch. Intern. Med. 166(13), 1403-1409 (2006). (Pubitemid 44036353)
79. King DE, Mainous AG 3rd, Geesey ME. Adopting moderate alcohol consumption in middle age: subsequent cardiovascular events. Am. J. Med. 121(3), 201-206 (2008). (Pubitemid 351317930)
80. Davis MA, Neuhaus JM, Moritz DJ, Lein D, Barclay JD, Murphy SP. Health behaviors and survival among middle-aged and older men and women in the NHANES I epidemiologic follow-up study. Prev. Med. 23(3), 369-376 (1994).
81. King DE, Mainous AG 3rd, Geesey ME. Turning back the clock: adopting a healthy lifestyle in middle age. Am. J. Med. 120(7), 598-603 (2007). (Pubitemid 46977317)
82. Haveman-Nies A, De Groot LP, Burema J, Cruz JA, Osler M, Van Staveren WA. Dietary quality and lifestyle factors in relation to 10-year mortality in older Europeans: the SENECA study. Am. J. Epidemiol. 156(10), 962-968 (2002). (Pubitemid 35304077)
83. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med. Care 36(8), 1138-1161 (1998). (Pubitemid 128456406)
84. Koelewijn-Van Loon MS, van der Weijden T, van Steenkiste B et al. Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. CMAJ 181(12), E267-E274 (2009).
85. O'Connor AM, Legare F, Stacey D. Risk communication in practice: the contribution of decision aids. BMJ 327(7417), 736-740 (2003). (Pubitemid 37176762)
86. Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health Educ. Q. 15(2), 175-183 (1988).
87. Bandura A. Health promotion by social cognitive means. Health Educ. Behav. 31(2), 143-164 (2004). (Pubitemid 38569365)
88. Ashenden R, Silagy C, Weller D. A systematic review of the effectiveness of promoting lifestyle change in general practice. Fam. Pract. 14(2), 160-176 (1997).
89. Lutfey KE, Wishner WJ. Beyond 'compliance' is 'adherence'. Improving the prospect of diabetes care. Diabetes Care 22(4), 635-639 (1999). (Pubitemid 29153053)
90. Burke LE, Dunbar-Jacob JM, Hill MN. Compliance with cardiovascular disease prevention strategies: a review of the research. Ann. Behav. Med. 19(3), 239-263 (1997). (Pubitemid 28196285)
91. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346(6), 393-403 (2002). (Pubitemid 34437694)
92. Seidel MC, Powell RO, Zgibor JC, Siminerio LM, Piatt GA. Translating the diabetes prevention program into an urban medically underserved community: a nonrandomized prospective intervention study. Diabetes Care 31(4), 684-689 (2008).
93. Mosca L, Mochari H, Liao M et al. A novel family-based intervention trial to improve heart health. FIT heart: results of a randomized controlled trial. Circ. Cardiovasc. Qual. Outcomes 1(2), 98-106 (2008).
94. Rigotti NA, Munafo MR, Stead LF. Smoking cessation interventions for hospitalized smokers: a systematic review. Arch. Intern. Med. 168(18), 1950-1960 (2008).
95. Fonarow GC, Gawlinski A, Moughrabi S, Tillisch JH. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP).Am. J. Cardiol. 87(7), 819-822 (2001). (Pubitemid 32244197)
96. Rahiman A, Saver JL, Porter V et al. In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months. J. Stroke Cerebrovasc. Dis. 17(1), 5-8 (2008).
97. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 365(9468), 1415-1428 (2005). (Pubitemid 40523737)
98. Brolin RE. Bariatric surgery and long-term control of morbid obesity. JAMA 288(22), 2793-2796 (2002). (Pubitemid 35425059)
99. Korner J, Woods SC, Woodworth KA. Regulation of energy homeostasis and health consequences in obesity. Am. J. Med. 122(4 Suppl. 1), S12-S18 (2009).
100. Walley AJ, Asher JE, Froguel P. The genetic contribution to non-syndromic human obesity. Nat. Rev. Genet. 10(7), 431-442 (2009).
101. Apovian CM, Bigornia S, Mott M et al. Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler. Thromb. Vasc. Biol. 28(9), 1654-1659 (2008).
102. Kursawe R, Eszlinger M, Narayan D et al. Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis. Diabetes 59(9), 2288-2296 (2010).
103. Mclaughlin T, Deng A, Gonzales O et al. Insulin resistance is associated with a modest increase in inflammation in subcutaneous adipose tissue of moderately obese women. Diabetologia 51(12), 2303-2308 (2008).
104. Apovian CM. The causes, prevalence, and treatment of obesity revisited in 2009: what have we learned so far? Am. J. Clin. Nutr. 91(1), S277-S279 (2010).
105. Galimanis A, Mono ML, Arnold M, Nedeltchev K, Mattle HP. Lifestyle and stroke risk: a review. Curr. Opin. Neurol. 22(1), 60-68 (2009).
106. Garfield AS, Heisler LK. Pharmacological targeting of the serotonergic system for the treatment of obesity. J. Physiol. 587(1), 49-60 (2009).
107. Zhang BB, Zhou G, Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 9(5), 407-416 (2009).
108. Goldstein MR, Mascitelli L, Pezzetta F. On treating metabolic syndrome: emphasise lifestyle change. Lancet Oncol. 11(5), 415 (2010).
109. Markus HS. Unravelling the genetics of ischaemic stroke. PLoS Med. 7(3), e1000225 (2010).
110. Assmann G, Schulte H, Seedorf U. The role of genetic predisposition and biomarkers in atherosclerosis. Int. Congress Series 1303, 95-102 (2007).
111. Touzé E, Rothwell PM. Heritability of ischaemic stroke in women compared with men: a genetic epidemiological study. Lancet Neurol. 6(2), 125-133 (2007). (Pubitemid 46097526)